Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « ISSN » - entrée « 2052-2975 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
2051-1426 < 2052-2975 < 2052-3211  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000777 (2020) R. Ozaras ; I. Ozdogru ; A A YilmazCoronavirus disease 2019 re-infection: first report from Turkey.
000810 (2020) I. Simova ; T. Vekov ; J. Krasnaliev ; V. Kornovski ; P. BozhinovHydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers.
000971 (2020) Y. Roussel ; D. RaoultInfluence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences.
000972 (2020) M. Million ; P. Gautret ; P. Colson ; Y. Roussel ; G. Dubourg ; E. Chabriere ; S. Honore ; J-M Rolain ; F. Fenollar ; P-E Fournier ; J-C Lagier ; P. Parola ; P. Brouqui ; D. RaoultClinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world.
000A62 (2020) C. Prodromos ; T. RumschlagHydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review.
000B04 (2020) Z. Khan ; D. Ghafoor ; A. Khan ; D. Ualiyeva ; S A Khan ; H. Bilal ; B. Khan ; A. Khan ; W. SajjadDiagnostic approaches and potential therapeutic options for coronavirus disease 2019.
000B05 (2021) E. ChabrièreDoes IHU-Méditerranée Infection influence Gilead Sciences' stock price?
000B35 (2020) Y. Roussel ; D. RaoultFirst evaluation of hydroxychloroquine recommendations in treating SARS-CoV-2.
000C54 (2020) H. Elbazidi ; O. ErraihMortality & Hydroxychloroquine; Politics & Pandemic: Strange liaisons lead to strange correlations: Mortalité & Hydroxychloroquine; Politiques & Pandémie: D'étranges liaisons impliquent d'étranges corrélations.
000D96 (2020) C C Prodromos ; T. Rumschlag ; T. PerchykHydroxychloroquine is protective to the heart, not harmful: a systematic review.
001030 (2020) H-P Piepho'Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences' by Roussel and Raoult (2020).
001910 (2020) S. Saqrane ; M A El MhammediReview on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19.
001911 (2020) R. Choudhary ; A K SharmaPotential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance.
001936 (2020) G. Venkat Kumar ; V. Jeyanthi ; S. RamakrishnanA short review on antibody therapy for COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i -k "2052-2975" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i  \
                -Sk "2052-2975" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    2052-2975
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021